Evogene Ltd. (EVGN)
Evogene Market Cap : 5.173M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 5.173M |
| October 08, 2026 | 5.394M |
| October 07, 2026 | 5.558M |
| October 06, 2026 | 5.735M |
| October 05, 2026 | 5.466M |
| October 02, 2026 | 5.753M |
| October 01, 2026 | 5.896M |
| September 30, 2026 | 5.375M |
| September 29, 2026 | 5.550M |
| September 28, 2026 | 5.144M |
| September 25, 2026 | 5.627M |
| September 24, 2026 | 5.739M |
| September 23, 2026 | 6.122M |
| September 22, 2026 | 6.680M |
| September 21, 2026 | 6.267M |
| September 18, 2026 | 6.754M |
| September 17, 2026 | 6.813M |
| September 16, 2026 | 6.711M |
| September 15, 2026 | 7.148M |
| September 14, 2026 | 6.698M |
| September 11, 2026 | 6.498M |
| September 10, 2026 | 6.505M |
| September 09, 2026 | 6.795M |
| September 08, 2026 | 6.871M |
| September 04, 2026 | 7.281M |
| Date | Value |
|---|---|
| September 03, 2026 | 7.377M |
| September 02, 2026 | 7.301M |
| September 01, 2026 | 7.049M |
| August 31, 2026 | 7.262M |
| August 28, 2026 | 7.439M |
| August 27, 2026 | 7.282M |
| August 26, 2026 | 7.350M |
| August 25, 2026 | 7.438M |
| August 24, 2026 | 7.566M |
| August 21, 2026 | 7.614M |
| August 20, 2026 | 7.587M |
| August 19, 2026 | 8.134M |
| August 18, 2026 | 7.886M |
| August 17, 2026 | 7.58M |
| August 14, 2026 | 6.256M |
| August 13, 2026 | 6.779M |
| August 12, 2026 | 6.372M |
| August 11, 2026 | 7.294M |
| August 10, 2026 | 6.584M |
| August 07, 2026 | 6.249M |
| August 06, 2026 | 7.133M |
| August 05, 2026 | 6.570M |
| August 04, 2026 | 6.768M |
| August 03, 2026 | 5.581M |
| July 31, 2026 | 4.904M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Compugen Ltd. | 201.76M |
| Pluri, Inc. | 10.32M |
| Scinai Immunotherapeutics Ltd. | 0.6726M |
| CollPlant Biotechnologies Ltd. | 5.070M |
| Regentis Biomaterials Ltd. | 11.24M |
Market Cap Related Metrics
| PS Ratio | 2.878 |
| Price | 0.3822 |
| Earnings Yield | -238.7% |